ID   ShK
AC   CVCL_B3QN
DR   Wikidata; Q110433218
RX   PubMed=11572760;
RX   PubMed=12967475;
CC   Population: Japanese.
CC   Sequence variation: Gene fusion; HGNC; HGNC:990; BCL2 + HGNC; HGNC:5853; IGL; Name(s)=IGL-BCL2 (PubMed=12967475).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (PubMed=12967475).
DI   NCIt; C8851; Diffuse large B-cell lymphoma
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 4
//
RX   PubMed=11572760; DOI=10.1111/j.1349-7006.2001.tb01183.x; PMCID=PMC5926849;
RA   Yonetani N., Ueda C., Akasaka T., Nishikori M., Uchiyama T., Ohno H.;
RT   "Heterogeneous breakpoints on the immunoglobulin genes are involved in
RT   fusion with the 5' region of BCL2 in B-cell tumors.";
RL   Jpn. J. Cancer Res. 92:933-940(2001).
//
RX   PubMed=12967475; DOI=10.1111/j.1349-7006.2003.tb01518.x; PMCID=PMC11160262;
RA   Maesako Y., Uchiyama T., Ohno H.;
RT   "Comparison of gene expression profiles of lymphoma cell lines from
RT   transformed follicular lymphoma, Burkitt's lymphoma and de novo
RT   diffuse large B-cell lymphoma.";
RL   Cancer Sci. 94:774-781(2003).
//